Equitable Trust Co. Acquires 76 Shares of Cardinal Health, Inc. $CAH

Equitable Trust Co. increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,888 shares of the company’s stock after buying an additional 76 shares during the period. Equitable Trust Co.’s holdings in Cardinal Health were worth $485,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of CAH. GAMMA Investing LLC raised its stake in Cardinal Health by 28.4% in the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock worth $965,000 after buying an additional 1,549 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in Cardinal Health by 25.8% in the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock worth $1,811,000 after buying an additional 2,694 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Cardinal Health by 15.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 35,790 shares of the company’s stock worth $4,931,000 after purchasing an additional 4,693 shares in the last quarter. Sagespring Wealth Partners LLC acquired a new position in shares of Cardinal Health during the first quarter worth $233,000. Finally, Insigneo Advisory Services LLC acquired a new position in shares of Cardinal Health during the first quarter worth $285,000. Institutional investors own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Stock Up 1.0%

Shares of CAH stock opened at $155.72 on Thursday. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The stock has a market capitalization of $37.00 billion, a PE ratio of 24.14, a P/E/G ratio of 1.30 and a beta of 0.71. The firm has a 50 day moving average of $151.90 and a two-hundred day moving average of $151.48.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter last year, the company posted $1.84 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent analyst reports. Robert W. Baird upped their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Evercore ISI lowered their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Leerink Partners boosted their price objective on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.